A Global, Phase 1/2, Open-label, Dose Escalation Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of mRNA-3927 in Participants with Propionic Acidemia
Clinical Trial Grant
Administered By
Pediatrics, Medical Genetics
Awarded By
Moderna Therapeutics, Inc.
Start Date
February 12, 2021
End Date
April 30, 2024
Administered By
Pediatrics, Medical Genetics
Awarded By
Moderna Therapeutics, Inc.
Start Date
February 12, 2021
End Date
April 30, 2024